Francesco Baratta

Pubblicazioni

Titolo Pubblicato in Anno
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia JAMA CARDIOLOGY 2024
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2024
Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease CARDIOVASCULAR DIABETOLOGY 2024
Risk of adverse events in anticoagulated patients with atrial fibrillation and non-alcoholic fatty liver disease THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2024
Diet and metabolic syndrome. A narrative review INTERNAL AND EMERGENCY MEDICINE 2023
Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Predictors of weight loss in patients with obesity treated with a Very Low-Calorie Ketogenic Diet FRONTIERS IN NUTRITION 2023
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2023
PAD4-Induced NETosis Via Cathepsin G-Mediated Platelet-Neutrophil Interaction in ChAdOx1 Vaccine-Induced Thrombosis-Brief Report ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY 2023
Challenges in Improving Adherence to Diet and Drug Treatment in Hypercholesterolemia Patients INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 2022
Added fructose in non-alcoholic fatty liver disease and in metabolic sindrome. a narrative review NUTRIENTS 2022
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis ANTIOXIDANTS 2022
Metabolic syndrome but not fatty liver-associated genetic variants correlates with glomerular renal function decline in patients with non-alcoholic fatty liver disease BIOMEDICINES 2022
Prevention and management of type ii diabetes chronic complications. the role of polyphenols (mini-review) CURRENT MEDICINAL CHEMISTRY 2022
High compliance to mediterranean diet associates with lower platelet activation and liver collagen deposition in patients with nonalcoholic fatty liver disease NUTRIENTS 2022
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study ANTIOXIDANTS 2022
Extra virgin olive oil reduces gut permeability and metabolic endotoxemia in diabetic patients NUTRIENTS 2022
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): implication for cardiovascular risk stratification ATHEROSCLEROSIS 2022
Twelve variants polygenic score for low-density lipoprotein cholesterol distribution in a large cohort of patients with clinically diagnosed familial hypercholesterolemia with or without causative mutations JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma